Regulation & law · 31/01/2022Updated: 10/17/2026 · 1 min read
Federal Judge Approves Pfizer's Acquisition of Mylan Pharmaceuticals, Rejects Erythropoietin Biosimilar Proposal
Summary
U.S. District Judge Bradley H. Chesler has approved Pfizer's acquisition of Mylan Pharmaceuticals, rejecting a proposal for a biosimilar version of Mylan's erythropoietin product, which is used to treat anemia in patients with chronic kidney disease.